Opraz O 20mg/4mg Tablet
By Opraz O
Rx
10 Tablet in a Strip

Composition
Ondansetron(20mg) + Omeprazole(4mg)

Manufacturer - Biosys Medisciences
c-7, dwarika puri, jamna lal bajaj marg, c-scheme jaipur-302001 (rajasthan)

Expires on or after
July, 2025

liver
When using Opraz O 20mg/4mg Tablet, caution is advised for individuals with severe liver disease. It may be necessary to adjust the dosage of this medication in such cases. It is important to consult with your doctor before starting treatment with Opraz O 20mg/4mg Tablet, especially if you have liver issues. In situations where patients with liver disease need to take this medicine for an extended period, a lower dose might be recommended. Always follow your healthcare provider's guidance to ensure the safe and effective use of Opraz O 20mg/4mg Tablet.

kidney
Opraz O 20mg/4mg Tablet is safe for patients with kidney disease. No dose adjustment needed.

alcohol
When taking Opraz O 20mg/4mg Tablet, caution is advised when consuming alcohol. It is important to consult your doctor regarding alcohol intake.

driving
Caution Opraz O 20mg/4mg Tablet may cause dizziness and visual disturbances, affecting driving ability.

pregnancy
Opraz O 20mg/4mg Tablet may be unsafe during pregnancy. Limited human studies and animal studies show potential harm to the baby. Your doctor will assess the benefits and risks before prescribing. Kindly consult your doctor.

breastfeeding
Opraz O 20mg/4mg Tablet is likely safe for breastfeeding mothers, as limited human data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹50
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025